Business
Medicinal Herbs Market Growing at 4.4% CAGR; Givaudan, Starwest Botanicals, Nexira, Indena Key Players
Medicinal Herbs Market Size and Share Forecast Outlook 2025 to 2035 ROCKVILLE, MD, UNITED STATES, April 13, 2026 /EINPresswire.com/ -- According to
About this update from Givaudan Sa
[{"type":"text","content":" Medicinal Herbs Market Size and Share Forecast Outlook 2025 to 2035 ROCKVILLE, MD, UNITED STATES, April 13, 2026 /EINPresswire.com/ -- According to Fact.MR’s latest analysis, the global medicinal herbs market is valued at USD 6.4 billion in 2025 and is projected to reach USD 9.8 billion by 2035, expanding at a CAGR of 4.4%. 𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗠𝗮𝗿𝗸𝗲𝘁 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝘀, 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗕𝗲𝗻𝗰𝗵𝗺𝗮𝗿𝗸𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗣𝗿𝗶𝗰𝗶𝗻𝗴 𝗧𝗿𝗲𝗻𝗱𝘀: https://www.factmr.com/connectus/sample?flag=S&rep_id=4070 The market is expected to create an incremental opportunity of approximately USD 3.4 billion during the forecast period. The industry is transitioning from traditional herbal consumption to standardized, science-backed botanical therapeutics, driven by increasing demand for preventive healthcare, natural remedies, and clean-label products. Medicinal herbs are gaining traction across nutraceuticals, functional foods, and personal care applications, positioning them as a core pillar of the global wellness economy. Quick Stats • Market Size (2025): USD 6.4 Billion • Market Size (2026): USD 6.7 Billion (estimated) • Forecast Value (2035): USD 9.8 Billion • CAGR (2025–2035): 4.4% • Incremental Opportunity: ~USD 3.4 Billion • Leading Product Type: Whole Dried Herbs – ~42% share • Leading Application: Nutraceuticals – ~44% share • Leading Region: Asia-Pacific • Key Players: Martin Bauer Group, Naturex, Nexira, Indena S.p.A., Givaudan SA Executive Insight for Decision Makers The market is shifting toward standardized, traceable, and clinically validated herbal solutions. • Herbal ingredient suppliers must invest in quality standardization and scientific validation • Manufacturers should develop value-added extracts and formulations • Investors should focus on companies with integrated sourcing and processing capabilities Risk: Companies relying on unstandardized or wild-harvested supply chains risk regulatory rejection and inconsistent product quality. Market Dynamics Key Growth Drivers • Increasing consumer preference for natural and plant-based healthcare solutions • Growing adoption of preventive healthcare and wellness lifestyles • Rising integration of traditional medicine systems (Ayurveda, TCM) into mainstream healthcare • Expansion of nutraceuticals and functional food industries Key Restraints • Lack of st...